Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASPOFUNGIN for Endocarditis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where CASPOFUNGIN was used for Endocarditis.

Most Reported Side Effects for CASPOFUNGIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,060 27.8% 596 468
Off label use 325 8.5% 144 157
Product use in unapproved indication 257 6.7% 55 52
Multiple organ dysfunction syndrome 215 5.6% 195 128
Drug resistance 194 5.1% 123 56
Septic shock 165 4.3% 124 106
Aspergillus infection 154 4.0% 90 70
Drug reaction with eosinophilia and systemic symptoms 136 3.6% 12 103
Systemic mycosis 129 3.4% 79 26
Pyrexia 128 3.4% 53 88
Death 120 3.2% 120 19
Pneumonia 120 3.2% 82 59
Bronchopulmonary aspergillosis 114 3.0% 74 75
Neutropenia 111 2.9% 51 70
Condition aggravated 109 2.9% 58 50

Other Indications for CASPOFUNGIN

Product used for unknown indication (383) Candida infection (343) Antifungal prophylaxis (334) Fungal infection (277) Aspergillus infection (258) Bronchopulmonary aspergillosis (211) Systemic candida (209) Antifungal treatment (196) Infection (118) Febrile neutropenia (92)

Other Drugs Used for Endocarditis

VANCOMYCIN (733) DAPTOMYCIN (506) GENTAMICIN (425) RIFAMPIN (296) AMOXICILLIN (279) CEFTRIAXONE (254) LINEZOLID (186) LEVOFLOXACIN (86) CEFAZOLIN (77) MEROPENEM (75)

Related Pages

CASPOFUNGIN Full Profile All Endocarditis Drugs CASPOFUNGIN Demographics CASPOFUNGIN Timeline